Eva Martinez‐Balibrea

2.7k total citations
43 papers, 1.7k citations indexed

About

Eva Martinez‐Balibrea is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Eva Martinez‐Balibrea has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 16 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Eva Martinez‐Balibrea's work include Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (11 papers) and Genetic factors in colorectal cancer (9 papers). Eva Martinez‐Balibrea is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (11 papers) and Genetic factors in colorectal cancer (9 papers). Eva Martinez‐Balibrea collaborates with scholars based in Spain, United States and Italy. Eva Martinez‐Balibrea's co-authors include Anna Martínez‐Cardús, José Luís Zamora Manzano, Albert Abad, Laura Layos, Cristina Bugés, Vicenç Ruiz de Porras, Alba Ginés, Sara Bystrup, Cátia Moutinho and Manel Esteller and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Eva Martinez‐Balibrea

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Martinez‐Balibrea Spain 20 937 898 399 237 209 43 1.7k
Anna Martínez‐Cardús Spain 23 1.3k 1.3× 813 0.9× 487 1.2× 221 0.9× 189 0.9× 48 1.9k
Mina Maftouh Iran 26 1.2k 1.3× 648 0.7× 752 1.9× 204 0.9× 189 0.9× 39 1.9k
Qingbin Cui China 22 1.0k 1.1× 679 0.8× 285 0.7× 83 0.4× 185 0.9× 49 1.8k
Zi‐Ning Lei United States 29 1.2k 1.3× 1.2k 1.4× 306 0.8× 121 0.5× 192 0.9× 72 2.2k
Sreenivasa R. Chinni United States 26 1.0k 1.1× 809 0.9× 464 1.2× 202 0.9× 389 1.9× 42 2.1k
Amro Aboukameel United States 31 2.0k 2.1× 1.0k 1.2× 611 1.5× 226 1.0× 166 0.8× 91 2.8k
Matthew Squires United States 25 1.1k 1.2× 825 0.9× 238 0.6× 181 0.8× 414 2.0× 71 1.9k
Zhenzhou Shen China 20 551 0.6× 689 0.8× 574 1.4× 249 1.1× 202 1.0× 54 1.5k
Rishil J. Kathawala United States 22 904 1.0× 1.2k 1.3× 183 0.5× 119 0.5× 116 0.6× 31 1.7k
Peter W. Eide Norway 14 1.1k 1.2× 843 0.9× 615 1.5× 408 1.7× 187 0.9× 19 2.0k

Countries citing papers authored by Eva Martinez‐Balibrea

Since Specialization
Citations

This map shows the geographic impact of Eva Martinez‐Balibrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Martinez‐Balibrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Martinez‐Balibrea more than expected).

Fields of papers citing papers by Eva Martinez‐Balibrea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Martinez‐Balibrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Martinez‐Balibrea. The network helps show where Eva Martinez‐Balibrea may publish in the future.

Co-authorship network of co-authors of Eva Martinez‐Balibrea

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Martinez‐Balibrea. A scholar is included among the top collaborators of Eva Martinez‐Balibrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Martinez‐Balibrea. Eva Martinez‐Balibrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verdura, Sara, Eva Martinez‐Balibrea, Joaquim Bosch‐Barrera, et al.. (2025). Mitochondrial priming and response to BH3 mimetics in “one-two punch” senogenic-senolytic strategies. Cell Death Discovery. 11(1). 91–91. 3 indexed citations
2.
Muñoz‐Mármol, Ana M, Bárbara Meléndez, Ainhoa Hernández, et al.. (2025). Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib. Cancers. 17(3). 375–375. 2 indexed citations
3.
4.
Romeo, Margarita, Anna Martínez‐Cardús, Eva Martinez‐Balibrea, et al.. (2018). Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer. International Journal of Molecular Sciences. 19(10). 3249–3249. 5 indexed citations
5.
Martínez‐Cardús, Anna, Sebastián Morán, Eva Musulén, et al.. (2016). Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer. Gastroenterology. 151(5). 961–972. 37 indexed citations
6.
Manzano, José Luís Zamora, Laura Layos, Cristina Bugés, et al.. (2016). Resistant mechanisms to BRAF inhibitors in melanoma. Annals of Translational Medicine. 4(12). 237–237. 177 indexed citations
7.
Porras, Vicenç Ruiz de, Sara Bystrup, Anna Martínez‐Cardús, et al.. (2016). Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway. Scientific Reports. 6(1). 24675–24675. 113 indexed citations
8.
Abad, Albert, José María Viéitez, Vicente Alonso, et al.. (2016). Effect of pharmacogenetic-based selection of first-line chemotherapy on response rate and R0 surgery in metastatic CRC patients.. Journal of Clinical Oncology. 34(15_suppl). 3530–3530. 2 indexed citations
9.
Gonçalves-Ribeiro, Samuel, Mireia Berdiel‐Acer, Antonio Soriano, et al.. (2016). Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells. Oncotarget. 7(37). 59766–59780. 48 indexed citations
10.
Martinez‐Balibrea, Eva, Anna Martínez‐Cardús, Alba Ginés, et al.. (2015). Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance. Molecular Cancer Therapeutics. 14(8). 1767–1776. 261 indexed citations
11.
Ginés, Alba, Sara Bystrup, Vicenç Ruiz de Porras, et al.. (2015). PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines. PLoS ONE. 10(5). e0123830–e0123830. 32 indexed citations
12.
Dias, Mafalda M., Jean‐Pierre Pignon, Christos S. Karapetis, et al.. (2014). The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis. The Pharmacogenomics Journal. 14(5). 424–431. 32 indexed citations
13.
Codony‐Servat, Jordi, Xabier García‐Albéniz, Carles Pericay, et al.. (2013). Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer. Medical Oncology. 30(1). 428–428. 4 indexed citations
14.
Porras, Vicenç Ruiz de, Anna Martínez‐Cardús, Àngels Ginès, et al.. (2012). 1001 CDK5 is Involved in Oxaliplatin Response and Resistance Acquisition Through Regulation of STAT3 Transcription Factor. European Journal of Cancer. 48. S242–S242. 1 indexed citations
15.
Yin, Ming, Eva Martinez‐Balibrea, Francesco Graziano, et al.. (2011). ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis. Clinical Cancer Research. 17(6). 1632–1640. 114 indexed citations
16.
Martinez‐Balibrea, Eva, Anna Martínez‐Cardús, Eva Musulén, et al.. (2009). Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin‐based chemotherapy. International Journal of Cancer. 124(12). 2905–2910. 60 indexed citations
17.
Martinez‐Balibrea, Eva, Enrique Aranda, E. Marcuello, et al.. (2009). Pharmacogenetic analysis of TS and UGT1A polymorphisms predictive for response and toxicity in Spanish patients with advanced colorectal cancer treated with first-line irinotecan and 5-fluorouracil. Journal of Clinical Oncology. 27(15_suppl). 4066–4066. 3 indexed citations
18.
Martinez‐Balibrea, Eva, Albert Abad, Enrique Aranda, et al.. (2008). Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. European Journal of Cancer. 44(9). 1229–1237. 58 indexed citations
19.
Fernández, Araceli Abad, et al.. (2004). Factores pronósticos del cáncer de colon y recto. 18(3). 153–160.
20.
Plasencia, Carmen, Patrick H. Rooney, Miquel Tarón, et al.. (2003). Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: Implications in the analysis of 5FU-acquired resistance mechanisms. International Journal of Oncology. 22(5). 945–53. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Martínez‐Cardús Breakdown of academic impact, for papers by Mina Maftouh Breakdown of academic impact, for papers by Qingbin Cui Breakdown of academic impact, for papers by Zi‐Ning Lei Breakdown of academic impact, for papers by Sreenivasa R. Chinni Breakdown of academic impact, for papers by Amro Aboukameel Breakdown of academic impact, for papers by Matthew Squires Breakdown of academic impact, for papers by Zhenzhou Shen Breakdown of academic impact, for papers by Rishil J. Kathawala Breakdown of academic impact, for papers by Peter W. Eide
Rankless by CCL
2026